Cargando…

Investigating the Impact of Selective Modulators on the Renin–Angiotensin–Aldosterone System: Unraveling Their Off-Target Perturbations of Transmembrane Ionic Currents

The renin–angiotensin–aldosterone system (RAAS) plays a crucial role in maintaining various physiological processes in the body, including blood pressure regulation, electrolyte balance, and overall cardiovascular health. However, any compounds or drugs known to perturb the RAAS might have an additi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Te-Ling, Wu, Sheng-Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530685/
https://www.ncbi.nlm.nih.gov/pubmed/37762309
http://dx.doi.org/10.3390/ijms241814007
_version_ 1785111544893276160
author Lu, Te-Ling
Wu, Sheng-Nan
author_facet Lu, Te-Ling
Wu, Sheng-Nan
author_sort Lu, Te-Ling
collection PubMed
description The renin–angiotensin–aldosterone system (RAAS) plays a crucial role in maintaining various physiological processes in the body, including blood pressure regulation, electrolyte balance, and overall cardiovascular health. However, any compounds or drugs known to perturb the RAAS might have an additional impact on transmembrane ionic currents. In this retrospective review article, we aimed to present a selection of chemical compounds or medications that have long been recognized as interfering with the RAAS. It is noteworthy that these substances may also exhibit regulatory effects in different types of ionic currents. Apocynin, known to attenuate the angiotensin II-induced activation of epithelial Na(+) channels, was shown to stimulate peak and late components of voltage-gated Na(+) current (I(Na)). Esaxerenone, an antagonist of the mineralocorticoid receptor, can exert an inhibitory effect on peak and late I(Na) directly. Dexamethasone, a synthetic glucocorticoid, can directly enhance the open probability of large-conductance Ca(2+)-activated K(+) channels. Sparsentan, a dual-acting antagonist of the angiotensin II receptor and endothelin type A receptors, was found to suppress the amplitude of peak and late I(Na) effectively. However, telmisartan, a blocker of the angiotensin II receptor, was effective in stimulating the peak and late I(Na) along with a slowing of the inactivation time course of the current. However, telmisartan’s presence can also suppress the erg-mediated K(+) current. Moreover, tolvaptan, recognized as an aquaretic agent that can block the vasopressin receptor, was noted to suppress the amplitude of the delayed-rectifier K(+) current and the M-type K(+) current directly. The above results indicate that these substances not only have an interference effect on the RAAS but also exert regulatory effects on different types of ionic currents. Therefore, to determine their mechanisms of action, it is necessary to gain a deeper understanding.
format Online
Article
Text
id pubmed-10530685
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105306852023-09-28 Investigating the Impact of Selective Modulators on the Renin–Angiotensin–Aldosterone System: Unraveling Their Off-Target Perturbations of Transmembrane Ionic Currents Lu, Te-Ling Wu, Sheng-Nan Int J Mol Sci Review The renin–angiotensin–aldosterone system (RAAS) plays a crucial role in maintaining various physiological processes in the body, including blood pressure regulation, electrolyte balance, and overall cardiovascular health. However, any compounds or drugs known to perturb the RAAS might have an additional impact on transmembrane ionic currents. In this retrospective review article, we aimed to present a selection of chemical compounds or medications that have long been recognized as interfering with the RAAS. It is noteworthy that these substances may also exhibit regulatory effects in different types of ionic currents. Apocynin, known to attenuate the angiotensin II-induced activation of epithelial Na(+) channels, was shown to stimulate peak and late components of voltage-gated Na(+) current (I(Na)). Esaxerenone, an antagonist of the mineralocorticoid receptor, can exert an inhibitory effect on peak and late I(Na) directly. Dexamethasone, a synthetic glucocorticoid, can directly enhance the open probability of large-conductance Ca(2+)-activated K(+) channels. Sparsentan, a dual-acting antagonist of the angiotensin II receptor and endothelin type A receptors, was found to suppress the amplitude of peak and late I(Na) effectively. However, telmisartan, a blocker of the angiotensin II receptor, was effective in stimulating the peak and late I(Na) along with a slowing of the inactivation time course of the current. However, telmisartan’s presence can also suppress the erg-mediated K(+) current. Moreover, tolvaptan, recognized as an aquaretic agent that can block the vasopressin receptor, was noted to suppress the amplitude of the delayed-rectifier K(+) current and the M-type K(+) current directly. The above results indicate that these substances not only have an interference effect on the RAAS but also exert regulatory effects on different types of ionic currents. Therefore, to determine their mechanisms of action, it is necessary to gain a deeper understanding. MDPI 2023-09-12 /pmc/articles/PMC10530685/ /pubmed/37762309 http://dx.doi.org/10.3390/ijms241814007 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Lu, Te-Ling
Wu, Sheng-Nan
Investigating the Impact of Selective Modulators on the Renin–Angiotensin–Aldosterone System: Unraveling Their Off-Target Perturbations of Transmembrane Ionic Currents
title Investigating the Impact of Selective Modulators on the Renin–Angiotensin–Aldosterone System: Unraveling Their Off-Target Perturbations of Transmembrane Ionic Currents
title_full Investigating the Impact of Selective Modulators on the Renin–Angiotensin–Aldosterone System: Unraveling Their Off-Target Perturbations of Transmembrane Ionic Currents
title_fullStr Investigating the Impact of Selective Modulators on the Renin–Angiotensin–Aldosterone System: Unraveling Their Off-Target Perturbations of Transmembrane Ionic Currents
title_full_unstemmed Investigating the Impact of Selective Modulators on the Renin–Angiotensin–Aldosterone System: Unraveling Their Off-Target Perturbations of Transmembrane Ionic Currents
title_short Investigating the Impact of Selective Modulators on the Renin–Angiotensin–Aldosterone System: Unraveling Their Off-Target Perturbations of Transmembrane Ionic Currents
title_sort investigating the impact of selective modulators on the renin–angiotensin–aldosterone system: unraveling their off-target perturbations of transmembrane ionic currents
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530685/
https://www.ncbi.nlm.nih.gov/pubmed/37762309
http://dx.doi.org/10.3390/ijms241814007
work_keys_str_mv AT luteling investigatingtheimpactofselectivemodulatorsonthereninangiotensinaldosteronesystemunravelingtheirofftargetperturbationsoftransmembraneioniccurrents
AT wushengnan investigatingtheimpactofselectivemodulatorsonthereninangiotensinaldosteronesystemunravelingtheirofftargetperturbationsoftransmembraneioniccurrents